AU Patent

AU2012221704B2 — Flumazenil complexes, compositions comprising same and uses thereof

Assigned to COERULEUS Ltd · Expires 2013-12-05 · 12y expired

What this patent protects

The present invention provides soluble complexes of flumazenil, methods for the preparation thereof, pharmaceutical compositions comprising same and use of said compositions for alleviating or counteracting the various types of hypersomnia, drowsiness, residual effects associated…

USPTO Abstract

The present invention provides soluble complexes of flumazenil, methods for the preparation thereof, pharmaceutical compositions comprising same and use of said compositions for alleviating or counteracting the various types of hypersomnia, drowsiness, residual effects associated with the administration of sleep/hypnotic drugs, alcohol intoxication or hepatic encephalopathy. The present invention is based in part on the unexpected discovery that flumazenil complexes are more soluble than flumazenil alone.

Drugs covered by this patent

Patent Metadata

Patent number
AU2012221704B2
Jurisdiction
AU
Classification
—
Expires
2013-12-05
Drug substance claim
No
Drug product claim
No
Assignee
COERULEUS Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.